Amani Kitali
- Hematology top 5%
- Multiple Myeloma Research and Treatments 21
- Chronic Myeloid Leukemia Treatments 1
-
- Cancer Treatment and Pharmacology 9
- Peptidase Inhibition and Analysis 5
-
- Protein Degradation and Inhibitors 8
- Amyloidosis: Diagnosis, Treatment, Outcomes 3
- Cancer therapeutics and mechanisms 1
-
- HIV/AIDS drug development and treatment 1
- Co-authors
- James W. HardinMohit NarangRobert M. RifkinKathleen ToomeyRafat AbonourShankar SrinivasanHoward R. TerebeloCristina Gasparetto
- Cited by
- HematologyOncologyMolecular Biology
- Journals
- Journal of Clinical Oncology (4 papers)Blood (4 papers)British Journal of Haematology (2 papers)
- Partner nations
- United States
In The Last Decade
Amani Kitali
20 papers receiving 252 citations
Peers
Comparison fields: 5 of 36
- Hematology 245
- Oncology 171
- Molecular Biology 193
- Genetics 25
- Family Practice 5
Countries citing papers authored by Amani Kitali
This map shows the geographic impact of Amani Kitali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amani Kitali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amani Kitali more than expected).
Fields of papers citing papers by Amani Kitali
This network shows the impact of papers produced by Amani Kitali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amani Kitali. The network helps show where Amani Kitali may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amani Kitali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2021 | 10 | |
| 4 | 2020 | 7 | |
| 5 | 2019 | 11 | |
| 6 | 2019 | 12 | |
| 7 | 2019 | 11 | |
| 8 | 2018 | 29 | |
| 9 | 2018 | 1 | |
| 10 | 2018 | 10 | |
| 11 | 2018 | 29 | |
| 12 | 2018 | 24 | |
| 13 | 2018 | 1 | |
| 14 | 2018 | 1 | |
| 15 | 2017 | 62 | |
| 16 | 2017 | 2 | |
| 17 | 2017 | 5 | |
| 18 | 2017 | 25 | |
| 19 | 2016 | 10 | |
| 20 | 2016 | 5 |
About Amani Kitali
Amani Kitali is a scholar working on Hematology, Oncology and Molecular Biology, having authored 22 papers that have together received 259 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (21 papers), Cancer Treatment and Pharmacology (9 papers), Protein Degradation and Inhibitors (8 papers), Peptidase Inhibition and Analysis (5 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Cancer therapeutics and mechanisms (1 paper), HIV/AIDS drug development and treatment (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Hematology (245 citations), Oncology (171 citations) and Molecular Biology (193 citations). Amani Kitali has collaborated with scholars based in United States. Frequent co-authors include James W. Hardin, Mohit Narang, Robert M. Rifkin, Kathleen Toomey, Rafat Abonour, Shankar Srinivasan, Howard R. Terebelo, Cristina Gasparetto, Sundar Jagannath and E. Dawn Flick. Their work appears in journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.